Elanco Animal Health Incorporated (ELAN) Q4 FY25 Earnings Call

Innovation momentum and deleveraging support 2026 growth, while inflation, inventory costs, and competition constrain margins.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-25
Length60 minutes
EPS$0.13
EPS consensus$0.11
Revenue$1.1B
Revenue consensus$1.1B

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All ELAN earnings ยท Back to ELAN overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.